RxDoctor Payments Data

Kevin Murphy, MD

Orthopedic Surgery · Tigard, ORNPI 1063410520

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,291 of the $89,869 with a category attached, or 69.3%. 23 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 39.5% of the total. Reporting peaked in 2019 at $54,300 and has fallen 99.2% since, to $408 in 2025.

$89,869in general payments, 2019–2025

Across 214 payments — averaging $419.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Therapeutics, Inc.$35K
  • Arthrex$21K
  • Pacira Pharmaceuticals Incorporated$16K
  • Steelhead Surgical Inc$12K
  • Zimmer Biomet$2K
  • Conformis, Inc.$1K
  • plus $3K from 17 others

What the payments were for

  • Speaking & faculty fees$62,29169%
  • Travel & lodging$14,94317%
  • Food & beverage$6,4857%
  • Education$6,1507%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopedic surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$99,014
Medicare patients
109
Services billed
2,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl62$502
Ondansetron Hcl47$163
Celecoxib17$135

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Tigard

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →